Φορτώνει......
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
Since the recent approval of vaccines against COVID-19, efficacy concerns emerged for MS patients treated with immunosuppressive drugs. We report our experience in four patients, under cladribine (two) or under ocrelizumab (two) treatment, all with low lymphocyte count, three of them vaccinated afte...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mult Scler Relat Disord |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier B.V.
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093161/ https://ncbi.nlm.nih.gov/pubmed/33990054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.102983 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|